Free Trial

Genus (GNS) Competitors

Genus logo
GBX 2,425 +40.00 (+1.68%)
As of 10:41 AM Eastern

GNS vs. HWDN, DPH, IGG, CTY, SMWH, CAR, PRP, AUK, STG, and BAY

Should you be buying Genus stock or one of its competitors? The main competitors of Genus include Howden Joinery Group (HWDN), Dechra Pharmaceuticals (DPH), IG Group (IGG), City of London (CTY), WH Smith (SMWH), Carclo (CAR), Prime People (PRP), Aukett Swanke Group (AUK), Strip Tinning (STG), and Bay Capital (BAY). These companies are all part of the "personal services" industry.

Genus vs. Its Competitors

Howden Joinery Group (LON:HWDN) and Genus (LON:GNS) are both personal services companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, profitability, earnings and institutional ownership.

Howden Joinery Group has a beta of 1.07, indicating that its share price is 7% more volatile than the S&P 500. Comparatively, Genus has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500.

70.6% of Howden Joinery Group shares are owned by institutional investors. Comparatively, 77.8% of Genus shares are owned by institutional investors. 0.5% of Howden Joinery Group shares are owned by insiders. Comparatively, 0.8% of Genus shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Howden Joinery Group has higher revenue and earnings than Genus. Howden Joinery Group is trading at a lower price-to-earnings ratio than Genus, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Howden Joinery Group£2.34B1.91£253.42M£46.6517.53
Genus£666.67M2.38£7.87M£12.06201.01

In the previous week, Genus had 4 more articles in the media than Howden Joinery Group. MarketBeat recorded 5 mentions for Genus and 1 mentions for Howden Joinery Group. Genus' average media sentiment score of 0.25 beat Howden Joinery Group's score of 0.15 indicating that Genus is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Howden Joinery Group
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Genus
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Howden Joinery Group presently has a consensus price target of GBX 963, indicating a potential upside of 17.75%. Genus has a consensus price target of GBX 2,650, indicating a potential upside of 9.28%. Given Howden Joinery Group's higher possible upside, research analysts clearly believe Howden Joinery Group is more favorable than Genus.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Howden Joinery Group
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.67
Genus
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Howden Joinery Group has a net margin of 10.82% compared to Genus' net margin of 1.18%. Howden Joinery Group's return on equity of 25.70% beat Genus' return on equity.

Company Net Margins Return on Equity Return on Assets
Howden Joinery Group10.82% 25.70% 10.70%
Genus 1.18%1.41%3.31%

Howden Joinery Group pays an annual dividend of GBX 21 per share and has a dividend yield of 2.6%. Genus pays an annual dividend of GBX 32 per share and has a dividend yield of 1.3%. Howden Joinery Group pays out 45.0% of its earnings in the form of a dividend. Genus pays out 265.3% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Howden Joinery Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Summary

Howden Joinery Group beats Genus on 10 of the 17 factors compared between the two stocks.

Get Genus News Delivered to You Automatically

Sign up to receive the latest news and ratings for GNS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GNS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GNS vs. The Competition

MetricGenusBiotechnology IndustryMedical SectorLON Exchange
Market Cap£1.59B£130.76M£5.52B£3.00B
Dividend Yield1.69%3.74%4.25%5.02%
P/E Ratio201.013.6027.95164.09
Price / Sales2.384,343.88438.79283,944.96
Price / Cash50.5613.1935.5327.97
Price / Book2.9342.238.254.62
Net Income£7.87M-£92.15M£3.23B£5.90B
7 Day Performance10.48%0.05%-0.13%2.12%
1 Month Performance24.87%4.25%7.21%8.54%
1 Year Performance42.82%164.99%27.45%64.39%

Genus Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GNS
Genus
0.6201 of 5 stars
GBX 2,425
+1.7%
GBX 2,650
+9.3%
+25.3%£1.59B£666.67M201.01480Analyst Forecast
HWDN
Howden Joinery Group
2.2742 of 5 stars
GBX 814
-1.5%
GBX 963
+18.3%
-13.2%£4.44B£2.34B17.4512,000
DPH
Dechra Pharmaceuticals
N/AN/AN/AN/A£4.40B£761.50M-15,464.002,457
IGG
IG Group
2.4918 of 5 stars
GBX 1,081
+0.2%
GBX 1,466
+35.6%
+24.5%£3.83B£913.00M7.212,754
CTY
City of London
N/AGBX 495.50
+0.7%
N/A+13.9%£2.45B£307.08M8.34N/ADividend Announcement
SMWH
WH Smith
3.1783 of 5 stars
GBX 1,046
-0.7%
GBX 1,430
+36.7%
-18.8%£1.35B£1.83B21.5814,935Dividend Increase
CAR
Carclo
N/AGBX 45
-2.9%
N/A+112.7%£33.04M£132.66M-10.021,059
PRP
Prime People
N/AN/AN/AN/A£8.15M£19.72M10.9813,100News Coverage
Gap Down
AUK
Aukett Swanke Group
N/AN/AN/AN/A£5.46M£23.61M-6.3232,200Gap Down
STG
Strip Tinning
N/AGBX 29.75
+19.0%
N/A-29.0%£5.42M£10.09M-1.814,060
BAY
Bay Capital
N/AGBX 5.50
flat
N/A+2.1%£3.85MN/A-2.712Gap Up

Related Companies and Tools


This page (LON:GNS) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners